USPTO serial 99408746
IVIGILANCE SQUARE
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- NANNEY, KATHERINE N
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with IVIGILANCE SQUARE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*
Plus Government fees of $600
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Seongnam-si, Gyeonggi-do, KR
Seongnam-si, Gyeonggi-do, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Young Joon Jung
Young Joon Jung KAIROS Law Firm, PLLC2001 L Street N.W. Suite 500Washington, DC 20036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable and recorded software for detecting, evaluating, analyzing, monitoring, processing, reporting, and managing pharmaceutical-related clinical data; Downloadable and recorded software for tracking, evaluating, analyzing, monitoring, processing, reporting, and managing drug safety using clinical data; Downloadable and recorded software for detecting, evaluating, analyzing, monitoring, processing, interpreting, reporting, managing, and preventing adverse drug reactions or side effects using clinical data; Downloadable and recorded pharmacovigilance software for monitoring and managing the safety of pharmaceutical products using clinical data; Downloadable computer programs for the design and management of clinical trials and research; Downloadable and recorded mobile device software for the design and management of clinical trials and research; Downloadable and recorded analytical software for analyzing clinical trial data | ACTIVE | — |
| 041 | Educational services, namely, conducting classes, seminars, conferences, workshops in the fields of medicine and pharmacy; Medical training and education services, namely, conferences, congresses, seminars, workshops and symposiums in the medicine and pharmacy fields; Medical education services, namely, providing live and on-line education courses in the field of medicine and pharmacy; Educational services, namely, organizing, arranging, and conducting in-person educational forums in the fields of clinical research and clinical trial operations, clinical research site management, and conduct of clinicians | ACTIVE | — |
| 042 | Research and development in the field of biotechnology; Computer programming services in the medical field; Consulting services relating to testing, inspection, and research of pharmaceuticals; Scientific research in the nature of conducting clinical trials for others; Clinical research services in the field of pharmaceuticals; Development of computer software for processing and analyzing clinical data; Medical research services, namely, conducting clinical trial research for others and clinical trial research management for others in the field of pharmaceuticals; Software as a service (SaaS) services featuring software for delivering streamlined clinical trial information and improving communication among stakeholders in clinical trials; Providing medical and scientific research information in the field of clinical trials for delivering streamlined clinical trial information and improving communication among stakeholders in clinical trials; Consulting services in the field of medical research in the nature of conducting clinical trials for others | ACTIVE | — |
| 044 | Medical services; Managed healthcare services; Provision of medical information; Provision of information in the field of medicine; Consumer-authorized clinical laboratory testing services being medical testing services that report results directly to the patient; Monitoring of clinical trial patients being medical care | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SELTA SQUARE Inc.
- Other trademarks owned by SELTA SQUARE Inc.
- Other trademarks in Class 009
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named IVIGILANCE SQUARE
- Prosecution event NOAM explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 21, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 26, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 26, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 20, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 30, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 11, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 11, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 11, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 26, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 26, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 26, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 26, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 4, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 16, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 9, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 23, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 23, 2025 | NWAP | NEW APPLICATION ENTERED | — |